145 related articles for article (PubMed ID: 19575225)
1. Efficacy of a single topical application of Advantage Multi (= Advocate) Topical Solution (10% imidocloprid + 2.5% moxidectin) in the treatment of dogs experimentally infected with Crenosoma vulpis.
Conboy G; Hare J; Charles S; Settje T; Heine J
Parasitol Res; 2009 Aug; 105 Suppl 1():S49-54. PubMed ID: 19575225
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Milbemax (milbemycin oxime + praziquantel) in the treatment of dogs experimentally infected with Crenosoma vulpis.
Conboy G; Bourque A; Miller L; Seewald W; Schenker R
Vet Parasitol; 2013 Dec; 198(3-4):319-24. PubMed ID: 24144516
[TBL] [Abstract][Full Text] [Related]
3. Imidacloprid plus moxidectin topical solution for the prevention of heartworm disease (Dirofiloria immitis) in dogs.
Arther RG; Bowman DD; Slone RL; Travis LE
Parasitol Res; 2005 Oct; 97 Suppl 1():S76-S80. PubMed ID: 16228279
[TBL] [Abstract][Full Text] [Related]
4. Experimental infection with Ancylostoma ceylanicum in dogs and efficacy of a spot on combination containing imidacloprid 10% and moxidectin 2.5% (Advocate/Advantage Multi, Bayer Animal Health).
Taweethavonsawat P; Chungpivat S; Satranarakun P; Traub RJ; Schaper R
Parasitol Res; 2010 May; 106(6):1499-502. PubMed ID: 20349196
[TBL] [Abstract][Full Text] [Related]
5. Laboratory Evaluation of the Efficacy of 10 % Imidacloprid + 2.5 % Moxidectin Topical Solution (Advantage® Multi, Advocate®) for the Treatment of Dirofilaria immitis Circulating Microfilariae in Dogs.
Bowman DD; Charles SD; Arther RG; Settje T
Parasitol Res; 2015 Aug; 114 Suppl 1():S165-74. PubMed ID: 26152417
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Adulticidal Efficacy of Imidacloprid 10 %/Moxidectin 2.5 % (w/v) Spot-on (Advocate®, Advantage® Multi) against Dirofilaria repens in Experimentally Infected Dogs.
Petry G; Genchi M; Schmidt H; Schaper R; Lawrenz B; Genchi C
Parasitol Res; 2015 Aug; 114 Suppl 1():S131-44. PubMed ID: 26152414
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of imidacloprid/moxidectin spot-on solution and fenbendazole in the treatment of dogs naturally infected with Angiostrongylus vasorum (Baillet, 1866).
Willesen JL; Kristensen AT; Jensen AL; Heine J; Koch J
Vet Parasitol; 2007 Jul; 147(3-4):258-64. PubMed ID: 17544583
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of imidacloprid 10%/moxidectin 1% spot-on formulation in the treatment of feline aelurostrongylosis.
Traversa D; Di Cesare A; Milillo P; Lohr B; Iorio R; Pampurini F; Schaper R; Paoletti B; Heine J
Parasitol Res; 2009 Aug; 105 Suppl 1():S55-62. PubMed ID: 19575226
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Persistent Preventive Efficacy of 2.5 % Moxidectin/10 % Imidacloprid Spot-on (Advocate®, Advantage® Multi) in Dogs Experimentally Infected with Angiostrongylus vasorum.
Böhm C; Petry G; Schmidt H; Raue K; Barthel F; Schaper R
Parasitol Res; 2017 Aug; 116(Suppl 1):1-10. PubMed ID: 28717944
[No Abstract] [Full Text] [Related]
10. Efficacy of imidacloprid 10%/moxidectin 1% spot-on formulation (Advocate®) in the prevention and treatment of feline aelurostrongylosis.
Heuer L; Petry G; Pollmeier M; Schaper R; Deuster K; Schmidt H; Blazejak K; Strube C; Di Cesare A; Traversa D; Schnyder M; McKay-Demeler J; von Samson-Himmelstjerna G; Mangold-Gehring S; Böhm C
Parasit Vectors; 2020 Feb; 13(1):65. PubMed ID: 32051008
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the efficacy of imidacloprid 10 % / moxidectin 2.5 % (Advocate®, Advantage® Multi, Bayer) for the prevention of Dirofilaria repens infection in dogs.
Genchi C; Genchi M; Petry G; Kruedewagen EM; Schaper R
Parasitol Res; 2013 Aug; 112 Suppl 1():81-9. PubMed ID: 23774842
[TBL] [Abstract][Full Text] [Related]
12. Assessment of parasitological findings in heartworm-infected beagles treated with Advantage Multi® for dogs (10% imidacloprid + 2.5% moxidectin) and doxycycline.
Savadelis MD; Ohmes CM; Hostetler JA; Settje TL; Zolynas R; Dzimianski MT; Moorhead AR
Parasit Vectors; 2017 May; 10(1):245. PubMed ID: 28526088
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of moxidectin 2.5% and imidacloprid 10% in the treatment of ocular thelaziosis by Thelazia callipaeda in naturally infected dogs.
Otranto D; Colella V; Crescenzo G; Solari Basano F; Nazzari R; Capelli G; Petry G; Schaper R; Pollmeier M; Mallia E; Dantas-Torres F; Lia RP
Vet Parasitol; 2016 Aug; 227():118-21. PubMed ID: 27523947
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy and safety of two treatment regimens with a topically applied combination of imidacloprid and moxidectin (Advocate) against generalised demodicosis in dogs.
Fourie JJ; Delport PC; Fourie LJ; Heine J; Horak IG; Krieger KJ
Parasitol Res; 2009 Aug; 105 Suppl 1():S115-24. PubMed ID: 19575232
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of a moxidectin/imidacloprid spot-on formulation (Advocate
Diakou A; Morelli S; Dimzas D; Di Cesare A; Capelli G; Parrinello C; Pollmeier M; Schaper R; Traversa D
Parasit Vectors; 2019 Nov; 12(1):519. PubMed ID: 31685011
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of sarcoptic mange and otoacariosis in dogs: results af a European field study.
Krieger K; Heine J; Dumont P; Hellmann K
Parasitol Res; 2005 Oct; 97 Suppl 1():S81-S88. PubMed ID: 16228280
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of the safety and efficacy of 10% imidacloprid + 2.5% moxidectin topical solution for the treatment of ear mite (Otodectes cynotis) infestations in dogs.
Arther RG; Davis WL; Jacobsen JA; Lewis VA; Settje TL
Vet Parasitol; 2015 May; 210(1-2):64-8. PubMed ID: 25801226
[TBL] [Abstract][Full Text] [Related]
18. Lungworm (Crenosoma vulpis) infection in dogs on Prince Edward Island.
Bihr T; Conboy GA
Can Vet J; 1999 Aug; 40(8):555-9. PubMed ID: 12001335
[TBL] [Abstract][Full Text] [Related]
19. Treatment of dog thelaziosis caused by Thelazia callipaeda (Spirurida, Thelaziidae) using a topical formulation of imidacloprid 10% and moxidectin 2.5%.
Bianciardi P; Otranto D
Vet Parasitol; 2005 Apr; 129(1-2):89-93. PubMed ID: 15817208
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of orally administered fluralaner (Bravecto™) or topically applied imidacloprid/moxidectin (Advocate®) against generalized demodicosis in dogs.
Fourie JJ; Liebenberg JE; Horak IG; Taenzler J; Heckeroth AR; Frénais R
Parasit Vectors; 2015 Mar; 8():187. PubMed ID: 25881320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
